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1. Introduction 
Sera from patients with Graves’ disease contain 
antibodies which inhibit the binding of thyrotrophin 
(TSH) to thyroid membranes [l-4]. The effect could 
be due to a direct interaction between the antibody 
and the TSH receptor or the antibody might inactivate 
the receptor indirectly by interacting with a different 
membrane component. Here, we describe attempts to 
distinguish between these two possibilities. Our inves- 
tigations demonstrate that Graves’ IgG has similar 
inhibiting effects on labelled TSH binding to mem- 
brane bound receptors, crude detergent solubilised 
receptors and detergent solubilised receptors purified 
by Sepharose-TSH affinity chromatography. Further- 
more, the effects of antibody are independent of 
detergent concentration and no evidence could be 
obtained for the formation of significant amounts of 
a complex consisting of antibody, solubilised recep- 
tors and TSH. These observations suggest hat Graves’ 
IgG contain antibodies which interact directly with 
the TSH receptor. 
2. Methods 
2.1. Preparation of IgG and solubilisation of TSH 
recep tars 
IgG was prepared from serum by. ammonium sul- 
phate precipitation (final cont. 1.6 M) followed by 
gel filtration of Sephadex G-200 in 50 mM NaCl; 
10 mM Tris-HCl (PH 7.5) (Tris/NaCl) [ 3,5]. IgG con- 
centrations were determined spectrophotometricahy 
[6] and adjusted by ultrafiltration (Amicon UM-10 
membrane). Crude thyroid membranes were prepared 
from porcine or human (Graves’) tissue and solubilised 
using Lubrol 12A9 (1% w/v) in Tris/NaCl containing 
ElsevierlNorth-Holland Biomedical Press 
15 mM iodoacetamide (Lubrol buffer) [3,4,7]. Por- 
cine or human thyroid tissue (1 g) gave a membrane 
preparation (1 gm equiv.) containing -50 mg protein 
[8] and 1 ml solubilised receptors contained -1 mg 
protein [9]. Highly purified bovine TSH (30 units/mg), 
a generous gift from Dr J. G. Pierce, was labelled with 
“‘1 using the iodogen method [lo] and receptor 
purified [2,3,11]. Of the labelled material, 65-75% 
could be bound by an excess of thyroid membranes 
and showed similar biological activity to the native 
material [ 111. 
2.2. Analysis of labelled TSH binding 
The binding of labelled TSH to crude thyroid 
membranes was studied by incubating the membranes 
(100 ~1) for 15 min at 20°C with 100 ~1 aliquots of 
test material (Graves’ IgG, TSH or other hormones 
diluted in normal pool IgG so that each 100 ~1 aliquot 
contained a total of 0.5 mg IgG). I-abelled TSH 
(100 ~1; 5000 cpm) diluted in Tris/NaCl containing 
lmg bovine serum albumin/ml (Tris/NaCl/BSA) was 
then added and incubation continued for 1 h at 37°C. 
Separation of bound and free labelled TSH was then 
achieved by centrifugation after addition of 0.5 ml 
ice-cold Tris/NaCl/BSA. All determinations were 
made in triplicate. In the case of studies with puri- 
fied and non-purified detergent solubilised TSH 
receptors (100 ~1 aliquots) a similar protocol was 
used except that bound and free labelled TSH were 
separated by precipitating receptor bound hormone 
by addition of polyethylene glycol (PEG; Mr 4000) 
to 15% (w/v) final cont. [4,7]. In experiments 
involving increased Lubrol concentrations, the 
detergent was added to give 15% (w/v) final cont. in 
the reaction mixtures. In some experiments bound 
and free hormone were also separated by gel filtra- 
tion (15 ml/h at 4’C) on Sephacryl S-300 (40 X 2.5 cm) 
in Lubrol buffer. Non-specific binding of labelled 
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TSH (*S% amount added) was taken as the 5% bound 
in the presence of IO mU untabelted TSH (Armour, 
1 u~t/nlg} and aft data were corrected for this param- 
eter. 
AIiquots (I 00 ~1) of Lubrol (I%, w/v) solubilised 
human or porcine TSH receptors with or without 
10 mU unlabelled TSH were incubated with 100 ~1 
labelled TSH (10 000 cpm) or ‘Z5f-IabeIled IgG [ 12, 
13 ] (20 000 cpm) for 12 h at O’C. Serum samples 
(100 1_r1 difu ted 1: 10 in Tr~s/Na~I) were then added 
and incubation continued for 12 h at 0°C. The mix- 
tures were then examined for the presence af TSH- 
TSH receptor complexes by precipitation with PEG 
or for the presence of TSH-TSH receptor-antibody 
complexes by precipitation with anti-human IgG. 
This was carried out by adding IOO#l of concentrated 
anti-human IgG and incubating for a further 12 h at 
0°C. All determinations were made in triplicate. 
a) b) 1.0 
$8 .8 
Partially purified bovine TSH (amour; 1 unit/mg) 
was coupled to CNBr-activated Sepharose (Pharmacia) 
using the procedure recommended by the manufac- 
turers. The final product contained -2 units TSH/mI 
settled gel and leakage of hormone from the gel could 
not be detected by TSH receptor assay. Lubrol (1%) 
solubilised porcine TSH receptors (10 ml containing 
-10 mg protein) were run (4 ml/h) through 5 ml 
~01umns of Sepharose-TSH at 20°C. The columns were 
then washed with 15 ml 1% Lubrol buffer and then 
I5 ml 1% Lubrol buffer adjusted to 2 M in NaCl, 2 ml 
fractions being collected throu~out. Each fraction 
was dialysed (at 0°C) for 24 h against Lubrol buffer 
(2 X 11) and 2 X 100 @ aliquots assayed for TSH 
binding activity and total protein [9]_ A typical aftin- 
ity column elutiun profile is shown in fig.2 The 2 
fractions eluted with 2 M NaCI and containing the 
highest TSH binding activity were pooled and used 
for further analysis. 
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Fig.1. (a) Scatchard analysis of TSH binding to: affinity-purified porcine receptors in 1% Lubrol(4); non-purified receptors in 1% 
Lubrol (0.) and non-purified receptors in 15% Lubrol (9). The data shown are typical of experiments with 2 different preparations 
of porcine TSH receptors. The siopes of the 3 lines were similar Q > 0.1) and could be interpreted as indicating an association 
constant of 10” M-‘. ibf Effect of Graves’ IgG on labelled TSH binding to Nan-pur~jed porcine, TSH receptors in 1% Lubrol (*> 
and 15% Lubrof (AL). Similar rest&s were obtained with IgG’s from 6 different Graves’ patients using porcine or human receptor 
preparations. B, = % ‘ZSf-labelled TSH specifically bound in the presence of normal pool IgG (40~50%); B = 5% &belled TSH 
bound in the presence of increasing amounts of Graves’ LgG. 
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3. Results Table 1 
In preliminary experiments the interaction of 
immunoglobulins (prepared by ammonium sulphate 
precipitation only [3]) from 36 different Graves’ sera 
with membrane-bound human TSH receptors were 
compared with their effects on non-purified detergent 
solubilised human TSH receptors. Inhibition of labelled 
TSH binding was similar with both receptor prepara- 
tions, linear regression analysis giving r = 0.83 
(P < 0.001). This study was then extended in order 
to assess whether increased dispersion of the thyroid 
membrane components using high concentrations of 
detergent could influence the interaction between 
Graves’ IgG and the TSH receptor. As shown in fig.1, 
increases in Lubrol concentration to 15% (w/v) did 
not influence the alibity of the Graves’ IgG to inhibit 
the TSH-TSH receptor interaction. TSH binding to 
the solubilised receptors showed similar characteristics 
at both detergent concentrations (fig.1). 
Solubilised humana 
TSH receptors 
incubated with labelled 
TSH followed by: 
% Total labelled TSH specif- 
ically precipitated with 
Anti IgG PEG 
Normal human serum 
pool 



















The possibility that detergent solubilised TSH 
receptor preparations might interact with both TSH 
and Graves’ IgG to form a complex containing both 
hormone and antibody was investigated by immuno- 
precipitation but as can be seen from table 1, anti- 
human IgG only precipitated very small amounts of 
labelled TSH from mixtures of labelled TSH, soluble 
receptors and Graves’ or Hashimoto sera. Precipitation 
with polyethylene glycol instead of anti-IgG demon- 
strated the presence of TSH-TSH receptor complexes 
and also showed that sera with high levels of receptor 
antibody activity induced some dissociation of the 
complex (table 1). 
Solubilised human TSH 
receptors incubated with 
labelled IgG followed by 
normal human serum 
pool. 
98 (% labelled IgG precip- 
itated) 
a Similar results were obtained using porcine TSH receptors 
b Hashimoto sera had high levels of microsomal and thyro- 
globulin antibodies and IgGs prepared from the Graves’ 
sera readily inhibited labelled TSH binding to particulate 
or solubilised receptors 
When solubilised porcine TSH receptors were run 
on Sepharose-TSH in Lubrol buffer, most of the pro- 
tein together with a small amount of TSH binding 
activity were unretarded (fig.2). Subsequent elution 
with 2 M NaCl eluted a small amount of protein with 
considerable TSH binding activity. SDS gel electro- 
phoresis of this preparation under reducing conditions 
[ 141 showed the presence of 8 major peptide units of 
20 000-150 000 Mr. Scatchard analysis [ 151 of TSH 
binding to both affinity purified and non-purified 
soluble porcine TSH receptors gave linear plots 
(r = 0.97 and 0.98, respectively; fig.1). Conventional 
interpretation of this type of analysis suggested that 
the purified receptors bound 7 mU TSH/mg protein 
compared with 0.15 mU TSH/mg protein for the non- 
purified preparations (representing a 50-fold puritica- 
tion). The tissue and hormonal specificities of these 
preparations were similar to those in [3,4,16] labelled 
TSH showing no detectable binding to non-thyroid 
preparations. In addition, hormones other than TSH 
did not influence labelled TSH binding to the various 
thyroid preparations except for large amounts (20 
units) of human chorionic gonadotrophin (Organon; 
1000 units/mg) which inhibited labelled TSH binding 
to purified and non-purified TSH receptor prepara- 
tions by -20% in agreement with [ 161. 
When labelled TSH was incubated with non-puri- 
fled porcine TSH receptors or affinity-purified recep- 
tors and the reaction mixture analysed on Sephacryl 
S-3 00, similar “‘1 elution profiles were obtained sim- 
ilar to those in [4,7]. Radioactivity was eluted as a 
small aggregate peak (Kav = 0.00) an intermediate 
peak (Kav = 0.24) and a more included component 
(Kav = 0.5 1). The aggregate and intermediate peaks 
consisted of TSH-TSH receptor complexes as their 
formation was completely inhibited by addition of 
10 mU unlabelled TSH to the receptors prior to la- 
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Fig.2. (a) Affinity chromatography of detergent solubilised porcine TSH receptors on Sepharose-TSH: protein content of each 
fraction (A); labehed TSH specifically bound 1.1. The elution profile shown is typicai of 6 separate xpt. (b) Interaction of 
Graves’ IgG with various porcine TSH receptor preparations. affinity purified receptors (=f; non-scurried sofubilised receptors {A); 
membrane bound receptors (*I. Simiiar rest&s were obtained with IgG preparations from 2 other Graves’ sera. See fig.l legend 
for definition of B and B,. 
belled hormone. The more included component 
(K, = 0.51) corresponded to uncomplexed TSH. 
Graves’ IgG inhibited labelled TSH binding to the 
purified receptor preparations in a similar manner to 
the membrane bound and non-purified receptors 
except that a slightly steeper dose-inhibition relation- 
ship was observed with the purified preparations 
(tig.2). 
4. Discussion 
Our studies demonstrate that the ability of Graves’ 
IgG inhibit labelled TSH binding to TSH receptors in 
thyroid membranes is maintained when: 
(i) The receptors are dispersed in detergent micelles; 
(ii) The concentration of detergent is increased to 
effect greater dispersion; 
20 
(iii) The receptors are purified by affinity chromatog- 
raphy on TSH-Sepharose. 
Furthermore, the binding of Graves’ IgG and TSH to 
the receptor appears to be mutually exclusive with no 
evidence for the formation of significant amounts of 
the type of antibody-receptor-hormone complexes 
observed with insulin receptor antibodies [ 171 and 
acetyl choline receptor antibodies [ 181. Consequently, 
the effects of Graves’ IgG on TSH binding appear to 
be due to the interaction of the antibody with a 
membrane component which is firmly bound to the 
TSH receptor and as such would appear to be a com- 
ponent of the TSH receptor molecule itself. The anti- 
body and hormone may well interact with different 
sites on the TSH receptor but these sites are closely 
related as evidenced by the inability of the receptor 
to bind antibody and hormone simultaneously. 
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